Searchable abstracts of presentations at key conferences on calcified tissues

ISSN 2052-1219 (online)

Bone Abstracts

Published by BioScientifica

Previous issue | Volume 7 | ICCBH2019

9th International Conference on Children's Bone Health

Poster Presentations

(1)

Table of contents

Abstract unavailable

Treatment of partial growth arrest using cylindrical costal osteochondral graft

Abstract unavailable

Applicability of the Tanner-Whitehouse 3 method to United Kingdom children born in the 21st century

Response of bone to mechanical stimulation in the offspring of MAVIDOS study mothers in a single centre; the effect of antenatal vitamin D supplementation

Pseudohypoparathyroidism type Ib initially masquerading as epileptic seizures due to Fahr's disease

Bone morphology patterns in children with osteogenesis imperfecta

Polyhydramnios: sole risk factor for non-traumatic fractures in two infants

Do lifestyle factors play a role on bone health in boys diagnosed with Autism Spectrum Disorder? Preliminary data from the Promoting bone and gut health in our children (PROUD) study

ba0007p10 | (1)

Radiographic evidence of zoledronic acid given during pregnancy – a case report

ba0007p11 | (1)

Reference values of cortical thickness, bone width, and Bone Health Index in metacarpals of children from age 0 y, as determined with an extension of the fully automated BoneXpert bone age method

ba0007p12 | (1)

Abstract unavailable

ba0007p13 | (1)

Clinical implications of modeling the maturational spurt

ba0007p14 | (1)

Bone health in children with congenital heart disease

ba0007p15 | (1)

TA-46 prevents premature synchondrosis and restores foramen magnum size in a mouse model of achondroplasia

ba0007p16 | (1)

Higher neonatal bone mineral content and lower IL-6 levels in offspring of overweight/obese women following antenatal exercise: The IMPROVE randomized controlled trial (RCT)

ba0007p17 | (1)

Sex and maturation effects on trabecular and cortical microarchitecture in children and young adults

ba0007p18 | (1)

Bone mass and fracture prevalence in childhood brain cancer survivors (CBCS) 2 or 5 years after off therapy

ba0007p19 | (1)

Progresive-deforming form of osteogenesis imperfecta in neonates – own experience

ba0007p20 | (1)

Abstract unavailable

ba0007p21 | (1)

Efficacy and safety of intravenous infusion of ibandronic acid in children with osteogenesis imperfecta

ba0007p22 | (1)

Tibia microarchitecture in children with recent fractures

ba0007p23 | (1)

What happens to the skeleton at the time of diagnosis of paediatric cancer?

ba0007p24 | (1)

The role of the RACK1-c-Src axis in regulation of osteoclast function

ba0007p25 | (1)

Short term mechanical stimulation using whole body vibration identifies differences in bone response between prepubertal boys with and without prior fracture

ba0007p26 | (1)

Parathyroid hormone is higher in infants with fracture as opposed to without fracture undergoing skeletal survey for suspected non-accidental injury, and is inversely associated with mean corpuscular haemoglobin content

ba0007p27 | (1)

Response to mechanical stimulation of bone in children with osteogenesis imperfecta and the effect of bisphosphonate therapy

ba0007p28 | (1)

Duchenne muscular dystrophy: preliminary results of the Risbo-DMD study

ba0007p29 | (1)

Rib cage anomalies in a cohort of osteogenesis imperfecta patients

ba0007p30 | (1)

Bone mass, sclerostin and body composition in women with anorexia nervosa: a 3-year follow-up after weight gain therapy

ba0007p31 | (1)

Determinants of survival in osteogenesis imperfecta (OI) Type II

ba0007p32 | (1)

Successful use of oral acetazolamide in symptomatic subcutaneous calcifications in hyperphosphatemic tumoral calcinosis

ba0007p33 | (1)

Unusual case of severe hypophosphataemic rickets and renal stones associated with valproate use

ba0007p34 | (1)

Bone metabolism and bone mineral density in Duchenne muscular dystrophy

ba0007p35 | (1)

Atypical fractures in pediatric patients with osteogenesis imperfect treated with zoledronic acid

ba0007p36 | (1)

ALPL gene mutation in a family

ba0007p37 | (1)

Generation of osteogenesis imperfecta type XIV zebrafish models

ba0007p38 | (1)

Clinical features and approach to treatment in pediatric patients with McCune-Albright syndrome: monocentric experience

ba0007p39 | (1)

Bone health outcomes in children with Duchenne Muscular Dystrophy

ba0007p40 | (1)

Stature and body weight more than age explain functionality level in children with Osteogenesis Imperfecta

ba0007p41 | (1)

Increased prevalence of fractures in poorly chelated children with beta thalassemia

ba0007p42 | (1)

FGF 23 measurements in children with fibrous dysplasia: useful or not?

ba0007p43 | (1)

Bone health is compromised in adult patients with childhood-onset autoimmune-polyendocrinopathy-candiadis-ectodermal dystrophy (APECED)

ba0007p44 | (1)

Bone mass and vertebral fractures in South African (SA) children on prolonged oral glucocorticoids (GCs) for chronic non-malignant illnesses

ba0007p45 | (1)

Osteogenesis imperfecta type 15 with neurological phenotype associated with homozygous WNT1 mutation and uniparental isodisomy for chromosome 12

ba0007p46 | (1)

Vertebral fractures are more prevalent than long bone fractures in boys with glucocorticoid-treated Duchenne Muscular Dystrophy: Results of a prospective observational study

ba0007p47 | (1)

Anorexia nervosa: weighing in on bone health surveillance: When should it be performed?

ba0007p48 | (1)

Does improved genetic screening make it more difficult to diagnose Osteogenesis Imperfecta?

ba0007p49 | (1)

Bone mineral density and vitamin D status in children with chronic neurological syndromes - clinical observations

ba0007p50 | (1)

Treatment with asfotase alfa for patients with infantile hypophosphatasia and screening plan of hypophosphatasia by low ALP level and dental findings in Korea

ba0007p51 | (1)

Higher dose of burosumab is needed for treatment of children with severe forms of X-linked hypophosphatemia

ba0007p52 | (1)

Variable familial expression of spondylometaphyseal dysplasia with coxa vara and a novel FN1 mutation

ba0007p53 | (1)

Successful treatment with enzyme replacement therapy in a girl with severe infantile Hypophosphatasia

ba0007p54 | (1)

Is oral health correlated with skeletal phenotype in primary metabolic bone diseases? A preliminary report of the Greek experience

ba0007p55 | (1)

Abstract unavailable

ba0007p56 | (1)

Unusual cause of abdominal pain in adolescent girl

ba0007p57 | (1)

Effective therapy with growth hormone of an adolescent patient with growth hormone deficiency and osteopetrosis: A case report

ba0007p58 | (1)

The validity of serum alkaline phosphatase to identify nutritional rickets in Nigerian children on a calcium-deprived diet

ba0007p59 | (1)

Effective treatment of a patient with Hypophosphatemic Rickets leading to normal adult height

ba0007p60 | (1)

FGF23-expressing osteocytes are confined to bone packets that completed primary mineralization in patients with chronic kidney disease on dialysis (CKD5D)

ba0007p61 | (1)

Biochemical and genetic analysis in patients with odontohypophosphatasia in Japan

ba0007p62 | (1)

Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in-vitro mutagenesis model

ba0007p63 | (1)

Bone geometry and microarchitecture deficits in children with Alagille syndrome

ba0007p64 | (1)

Missense mutations in ENPP1 result in osteoporosis in patients and is recapitulated in the ENPP1 loss of function murine model

ba0007p65 | (1)

Tumor induced osteomalacia in a 12-year-old girl: Case report

ba0007p66 | (1)

Bone densitometry and body composition in children with hypophosphatasia

ba0007p67 | (1)

Bone health outcomes in children and adolescents with neuromuscular disease

ba0007p68 | (1)

Clinical case of a child with a hereditary vitamin D dependent rickets type 1a, complicated by rachitic lung and oxygen dependence

ba0007p69 | (1)

Experience of implementation and monitoring of burosumab treatment in a multi-disciplinary setting

ba0007p70 | (1)

Metabolic bone disease of prematurity – comparing neonatal and endocrine approaches using a nationwide survey

ba0007p71 | (1)

Necessity of high dose and prolonged duration denosumab post stem cell transplant for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis

ba0007p72 | (1)

Burosumab experience in UK X-linked hypophosphataemia children under five years old

ba0007p73 | (1)

Burosumab initiation in a UK X-linked hypophosphataemia cohort: real-world use resonates with research evidence

ba0007p74 | (1)

Burosumab can improve pain and quality of life for children with X-linked hypophosphataemia and their families: a London centre's experience

ba0007p75 | (1)

Active vitamin D analogues and oral phosphate for the treatment of X-linked hypophosphataemia in paediatric patients: A systematic literature review and survey of expert opinion on current needs

ba0007p76 | (1)

Safety profile of asfotase alfa treatment of patients with hypophosphatasia: a pooled analysis

ba0007p77 | (1)

Long-term efficacy profile of asfotase alfa in the treatment of patients with hypophosphatasia: a pooled analysis

ba0007p78 | (1)

Abstract unavailable

ba0007p79 | (1)

Novel imaging approaches to the quantification of musculoskeletal alterations in X-linked hypophosphatemic rickets (XLH)

ba0007p80 | (1)

Characterization of pain in patients with fibrous dysplasia

ba0007p81 | (1)

Bone health in adolescent females with anorexia nervosa may be preserved by high lean mass

ba0007p82 | (1)

Tertiary hyperparathyroidism and post-operative hungry bone syndrome in a patient with X-linked hypophosphatemic rickets

ba0007p83 | (1)

Could digital X-ray radiogrammetry be an alternative for dual energy X-ray absorptiometry

ba0007p84 | (1)

Abstract unavailable

ba0007p85 | (1)

Neonatal calcinosis cutis due to a mutation in the GNAS gene

ba0007p86 | (1)

Disease-specific pathological traits of youth at risk of secondary osteoporosis as determined through peripheral Quantitative Computed Tomography

ba0007p87 | (1)

Assessment of bone density by DXA in poorly controlled children with β-Thalassemia: Correction for hepatic iron - overloadby manual analysis

ba0007p88 | (1)

Diagnostic performance of morphometric vertebral fracture analysis (MXA) in children using a 33-point software programme

ba0007p89 | (1)

Use of DXA and pQCT measurements to screen for fracture risk in 3 to 18 year old poorly chelated thalassaemic children

ba0007p90 | (1)

Osteogenesis imperfecta due to FKBP10 mutation- shift from high to low bone turnover

ba0007p91 | (1)

Bone health index by hand X-ray compared with bone mineral density by dual-energy X-ray absorptiometry in children with Duchenne muscular dystrophy

ba0007p92 | (1)

A little girl with bowing of legs, a short mother and a waddling sister: Metaphyseal Chondrodysplasia, Schmid type

ba0007p93 | (1)

Assessing the ability of vibration analysis to differentiate wrist and ankle fractures from sprains in children

ba0007p94 | (1)

Characteristics of ultradistal radius bone density during childhood: results from the Bone Mineral Density in Childhood Study

ba0007p95 | (1)

Detection of intact FGF23 using a novel well-characterized ELISA

ba0007p96 | (1)

Radiofrequency echographic multispectrometry (REMS): a new approach for osteoporosis diagnosis in adolescents

ba0007p97 | (1)

Association of serum alkaline phosphatase with radiological rickets severity in children with X-linked hypophosphataemia on conventional therapy

ba0007p98 | (1)

The effect of vitamin D on bone health assessed by radiogrammetry: a double-blind placebo-controlled vitamin D supplementation trial in infants

ba0007p99 | (1)

Pre and post-natal achondroplasia, retrospective series of 64 consecutives cases with analyze of the diagnostic methods and timing issues

ba0007p100 | (1)

High-resolution MRI assessment of the muscle-fat-bone unit in young adults with childhood onset Crohn's disease

ba0007p101 | (1)

Vitamin D levels among Lebnaese children: Do we need to alter normal level?

ba0007p102 | (1)

Vitamin D deficiency in children in Israel: A cross-sectional study and possible associated factors

ba0007p103 | (1)

Abstract unavailable

ba0007p104 | (1)

Vitamin D deficiency nutritional rickets presenting to secondary care in children (<16 Years) – A United Kingdom surveillance study

ba0007p105 | (1)

Respiratory health impacts quality of life for adults with OI

ba0007p106 | (1)

Scoliosis and cardiopulmonary outcomes in adults with osteogenesis imperfecta: a pilot study

ba0007p107 | (1)

Sex differences in the longitudinal associations between body composition and bone stiffness index in European children and adolescents

ba0007p108 | (1)

Abstract unavailable

ba0007p109 | (1)

Fracture prevalence in children 0–19 years-old in Mexico: A 10-year cross-sectional analysis

ba0007p110 | (1)

Cost-effectiveness of a Vitamin D supplementation programme in pregnant women and children to prevent rickets in the UK

ba0007p111 | (1)

Vitamin D dependent rickets type 1 caused by CYP27B1 mutation

ba0007p112 | (1)

Case report: investigation of an osteolytic lesion leading to the diagnosis of congenital generalized lipodystrophy due to a novel AGPAT2 mutation

ba0007p113 | (1)

Next-generation sequence and biomarker levels in the patients with early-onset chronic non-bacterial osteomyelitis from North Caucasian region of Russia

ba0007p114 | (1)

Hypophosphatasia in Japan: ALPL mutation analysis in 98 patients

ba0007p115 | (1)

Mabry Syndrome is a cause of hyperphosphatasia and mental retardation

ba0007p116 | (1)

Molecular genetic diagnosis and genotype-phenotype correlations in children and adolescents with recurrent fractures

ba0007p117 | (1)

Use of Lego® to explain genetic variations in type 1 collagen – a pilot study

ba0007p118 | (1)

Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome

ba0007p119 | (1)

A novel mutation in FAM111A gene in child with Kenny-Caffey syndrome type 2 presenting with short statue, medullary stenosis and hypoparathyroidism

ba0007p120 | (1)

Mutational and phenotypic spectra in 137 Russian patients with inherited forms of rickets

ba0007p121 | (1)

An Acvr1[R258G] ‘conditional on' mouse model of atypical fibrodysplasia ossificans progressiva (FOP) is Activin A dependent

ba0007p122 | (1)

Congenital hyperinsulinism of infancy in a child with autosomal dominant hypocalcaemia type 1 due to an activating calcium sensing receptor mutation

ba0007p123 | (1)

Odontochondrodysplasia in association with a TRIP11 mutation

ba0007p124 | (1)

Heterozygous CDC73 mutation causing parathyroid adenoma in an adolescent girl presenting with mental health issues

ba0007p125 | (1)

SCN8a mutations and osteoporosis. Is osteocyte dysfunction the cause or the consequence?

ba0007p126 | (1)

Anemia - novel clinically significant finding during intravenous pamidronate therapy of children diagnosed with osteogenesis imperfecta

ba0007p127 | (1)

Burosumab therapy in pediatric patients with X-linked hypophosphatemia improves body composition

ba0007p128 | (1)

Growth hormone effect on bone mineral density in a girl with osteogenesis imperfecta – a case presentation

ba0007p129 | (1)

A smartphone-based survey of frequency and severity of adverse effects following bisphosphonate therapy in a Tertiary Paediatric Centre

ba0007p130 | (1)

Off label uses of pamidronate in rare pediatric bone diseases (Jansen's Metaphyseal Chondrodysplasia and Generalized Arterial Calcification of Infancy): A four year perspective

ba0007p131 | (1)

Use of intravenous pamidronate in pediatric acute lymphoblastic leukemia patients with osteonecrosis (ON) results in reduced pain and improved radiologic outcome of ON lesions: Long- term follow-up over 15-years

ba0007p132 | (1)

A prospective study of 17 consecutive pediatric patients with chronic non-bacterial osteomyelitis treated with intravenous pamidronate over a 15 year period at a single center reveals excellent clinical and radiologic outcome initially and after flare

ba0007p133 | (1)

Losartan reduces circulating TGFb and CTX and increases vertebral bone mass in the OIM mouse

ba0007p134 | (1)

First report of skin reaction with Zoledronic Acid

ba0007p135 | (1)

Oral ibandronate therapy in patients with osteogenesis imperfecta

ba0007p136 | (1)

Intravenous bisphosphonate treatment in severe infantile hypercalcemia associated with Williams Syndrome

ba0007p137 | (1)

Reversion to pamidronate after switch to zoledronic acid in children with bone disease

ba0007p138 | (1)

How early is early enough – Bisphosphonate treatment in Osteogenesis imperfecta

ba0007p139 | (1)

Growth hormone therapy in a child with severe short stature due to Miller-McKusick-Malvaux (3M) syndrome-2

ba0007p140 | (1)

Safety and effectiveness of stoss therapy in children

ba0007p141 | (1)

Hypercalcaemia and osteonecrosis of the jaw in association with denosumab use in the paediatric population

ba0007p142 | (1)

Protocol: a randomized trial of zoledronate in children with cerebral palsy

ba0007p143 | (1)

Intermittent bi-daily sub-cutaneous teriparatide infusion in children with hypoparathyroidism: a single-centre experience

ba0007p144 | (1)

A multi-criteria decision analysis of the value of burosumab for the treatment of paediatric patients with X-linked hypophosphatemia in Portugal

ba0007p145 | (1)

Nine-month follow-up data on biochemical, clinical, radiological and functional parameters in a clinical cohort of children at Evelina London Children's Hospital with X-linked hypophosphataemia treated with Burosumab

ba0007p146 | (1)

Does prior bisphosphonate therapy in children and adolescents with cerebral palsy alter surgical outcomes?

ba0007p147 | (1)

Changes in DXA Z-scores during bisphosphonate (BP) therapy in patients with osteogenesis imperfecta (OI) at a tertiary care hospital in South Africa

ba0007p148 | (1)

Management of foramen magnum stenosis in patients with achondroplasia: relative merit of clinical and radiological indications for foramen magnum decompression

ba0007p149 | (1)

Bone mineral changes in 43 children with osteogenesis imperfecta treated by pamidronate

ba0007p150 | (1)

Osteogenesis imperfecta: skeletal outcomes after bisphosphonates discontinuation at final height

ba0007p151 | (1)

The safety and efficacy of denosumab versus zoledronic acid in the treatment of pediatric osteoporosis: a randomized controlled pilot trial

ba0007p152 | (1)

An evaluation of the rebound phenomenon during denosumab therapy in children with low turnover osteoporosis

ba0007p153 | (1)

Long-term growth hormone treatment alters glucose metabolism in achondroplasia

ba0007p154 | (1)

Self-reported sedentary time is negatively associated with microarchitecture of the tibia

ba0007p155 | (1)

Gender specific paediatric reference data for muscle function parameters assessed using jumping mechanography

ba0007p156 | (1)

Patients with nephropatic cystinosis display lower cortical thickness and grip strength

ba0007p157 | (1)

Gonadotrophin releasing hormone analogues utilised in late and post-pubertal adolescents causes a reduction in bone density in transgender teenagers attending a national gender dysphoria clinic

ba0007p158 | (1)

Association of grip strength and body composition in Indian boys and girls

ba0007p159 | (1)

Determinants of muscle function in 6 to 11 year old rural Indian children

ba0007p160 | (1)

Assessment of muscle mass and function in Indian children with type 1 diabetes

ba0007p161 | (1)

Endocrinological complications in Czech paediatric patients with Duchenne muscular dystrophy

ba0007p162 | (1)

Bone monitoring and morbidity in adults with duchenne muscular dystrophy: Challenges in implementation of standards of care

ba0007p163 | (1)

Prenatal oligohydramnios is associated with hip shape in adolescent males

ba0007p164 | (1)

Musculoskeletal deficits persist up to two years despite anti-TNF-alpha antibody therapy in children with Crohn's disease: Results of a prospective, observational inception cohort study

ba0007p165 | (1)

Fibroblast growth factor-21 (FGF-21) – marker of mineral bone disorder

ba0007p166 | (1)

The ketogenic diet and bone density: a retrospective longitudinal cohort study

ba0007p167 | (1)

Children's multivitamins do not contain sufficient vitamin D

ba0007p168 | (1)

Abstract unavailable

ba0007p169 | (1)

Rescue diet restores bone matrix mineralization in mice with a non-functioning vitamin D receptor

ba0007p170 | (1)

Serum 25-hydroxyvitamin D requirements to prevent rickets in Nigerian children on a calcium-deprived diet

ba0007p171 | (1)

Seasonal variations in vitamin D status in children with haematological malignancies in Sweden

ba0007p172 | (1)

Cow's milk allergic infants on amino acid-based medical nutrition formula maintain adequate serum concentrations of phosphorus, calcium and magnesium despite the use of acid-suppressive medication

ba0007p173 | (1)

Motor and nutritional aspects of individuals with osteogenesis imperfecta assisted in Brazilian midwest region

ba0007p174 | (1)

Supplementation of children with type 1 diabetes with milk or pharmacological calcium for improving bone health – a randomized controlled trial

ba0007p175 | (1)

Dietary behaviours and compromised nutritional intakes in children with Osteogenesis Imperfecta

ba0007p176 | (1)

Prevalence of vitamin D deficiency in newly diagnosed children with cancer

ba0007p177 | (1)

Feasibility of a 13-week targeted exercise intervention on tibial bone mineral density in adolescents with Developmental Coordination Disorder

ba0007p178 | (1)

The role of hydrotherapy in the management of children with severe Osteogenesis Imperfecta

ba0007p179 | (1)

Clinical and radiological characteristics of children's forearm deformations with hereditary multiple exostosis (Clinical observation)

ba0007p180 | (1)

A retrospective review of modern spine surgery in the skeletal dysplasia population

ba0007p181 | (1)

Walking quality of children with healed Perthes disease

ba0007p182 | (1)

Handgrip strength as functionality and independence indicative in Osteogenesis Imperfecta

ba0007p183 | (1)

Functional outcomes of an adult with Osteogenesis Imperfecta after rehabilitation post-bilateral Girdlestone procedure: a case report

ba0007p184 | (1)

Material based on bioactive glass to replace bone defects in children after removal of tumors

ba0007p185 | (1)

High impact exercise to improve musculoskeletal outcomes in Crohn's disease: a feasibility questionnaire

ba0007p186 | (1)

Severe osteoporosis with life threatening vertebral fractures in a 15-years-old boy with juvenile idiopathic arthritis: a successful spinal cord decompression and posterior spinal fusion Th2-Th12

ba0007p187 | (1)

Increased prevalence of overweight and obesity and its clinical predictors in children affected by X-linked hypophosphatemia

ba0007p188 | (1)

Impact of type 1 diabetes mellitus on skeletal integrity and strength in adolescents aged 12 to 16 years; as assessed by High Resolution peripheral Quantitative Computed Tomography (HRpQCT)

ba0007p189 | (1)

Cleidocranial dysplasia: a patient with severe dental phenotype

ba0007p190 | (1)

Cone-shaped epiphyses involving the knees: report of a case and differential diagnosis

ba0007p191 | (1)

Supporting the emotional well-being of children living with osteogenesis imperfecta; an upstream health promotion initiative

ba0007p192 | (1)

Developing a high chair to meet the needs of infants with Achondroplasia; a collaboration between Evelina London Children's Hospital and Brunel University

ba0007p193 | (1)

Double trouble: A case of trisomy 21 and achondroplasia

ba0007p194 | (1)

Skeletal dysplasia in Saul Wilson syndrome

ba0007p195 | (1)

Growth velocity measured by biomarker, COLX, in Achondroplasia

ba0007p196 | (1)

Sleep related problems in children with osteogenesis imperfecta

ba0007p197 | (1)

A playful type of intervention for infants with osteogenesis imperfecta

ba0007p198 | (1)

The multidisciplinary team (MDT) approach: What does it look like and why does it matter? An illustration of a true MDT approach to provide holistic care for a child with severe and complex osteogenesis imperfecta

ba0007p199 | (1)

Diversity of outcomes in randomised trials of interventions for children with osteogenesis imperfecta

ba0007p200 | (1)

Whole body vibration training for children and adolescents with congenital myopathy

ba0007p201 | (1)

Juvenile dermatomyositis (JDM) and hypoparathyroidism (HP) in an adolescent girl

ba0007p202 | (1)

Vibration therapy improves mobility and has no detrimental impact on bone health in adolescents with mild cerebral palsy independent of daily protocol duration (9 minutes/day vs. 15 minutes/day)

ba0007p203 | (1)

Side-alternating vibration training improves mobility and has no detrimental impact on bone health in young children with mild-moderate cerebral palsy

ba0007p204 | (1)

A qualitative analysis of the burden-of-illness associated with X-linked hypophosphataemia (XLH) in children and adolescents

ba0007p205 | (1)

Bone mineral density in surgical hemivertebrae treatment in a prematurely born child − a case study

ba0007p206 | (1)

Robot-assisted exercises in children with cerebral palsy – a case study

ba0007p207 | (1)

Group exercises aimed at poor body posture correction assisted by humanoid robot – A case study

ba0007p208 | (1)

Motor developmental outcomes in 2 babies with very severe osteogenesis imperfecta (type II)

ba0007p209 | (1)

Persistently low trabecular bone mineral density and normal bone strength at the radius over 3 years after simultaneous pancreas kidney transplantation

ba0007p210 | (1)

Premature physeal closure following 13 -cis - retinoic acid administration in neuroblastoma

ba0007p211 | (1)

Value of osteogenesis imperfecta clinical nurse specialists to families and consultants across five UK centres

ba0007p212 | (1)

Genetic loss of heparanase does not inhibit osteochondromas in Ext1 and Ext2 double heterozygous hereditary multiple osteochondroma mouse model

ba0007p213 | (1)

Evaluating a therapy-led school and nursery outreach service for children with Osteogenesis Imperfecta

ba0007p214 | (1)

Assessment of multidisciplinary care of children with osteogenesis imperfecta at The Royal Manchester Children's Hospital

ba0007p215 | (1)

Evaluating the natural history of subcutaneous fat necrosis

ba0007p216 | (1)

Dual diagnosis of autism and osteogenesis imperfecta: Case examples to illustrate the implications of dual diagnosis for enhanced outcomes for child and family

ba0007p217 | (1)

Abstract unavailable

ba0007p218 | (1)

Hypercalcemia and parathyroid hormone-related peptide expression in a 3 months old boy with Colon Hemangioendothelioma

ba0007p219 | (1)

Comparison of cell separation methods, using relative expression of specific growth plate zone markers in a pig model

ba0007p220 | (1)

New perspectives in diagnosis and management of optic neuropathy in fibrous dysplasia: utility of optical coherence tomography and computed tomography measurements

ba0007p221 | (1)

Speech and hearing impairment and respiratory complications in a large cohort of patients with Achondroplasia

ba0007p222 | (1)

Long-term clinical outcome in chronic recurrent multifocal osteomyelitis (CRMO): the Leiden cohort

ba0007p223 | (1)

A preliminary data of a prospective study on Iranian patients with osteogenesis imperfecta

ba0007p224 | (1)

A teenager with recurrent fractures and multiple bone lesions: a diagnostic challenge

ba0007p225 | (1)

A short girl with severe scoliosis and osteoporosis

ba0007p226 | (1)

The experience of canakinumab in 2 patients with primary tumor (tumoral) calcinosis

Bone Abstracts
ISSN 2052-1219 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more